News & Resources

Subscribe to NHLBI Press Releases
April 25, 2015

Two treatments yield similar results for children after cardiac arrest

A large-scale, multicenter study has shown that emergency body cooling does not improve survival rates or reduce brain injury in infants and children with out-of-hospital cardiac arrest more than normal temperature control.

Therapeutic hypothermia, or whole body cooling, can improve survival and health outcomes for adults after cardiac arrest and also for newborns with brain injury due to a lack of oxygen at birth.  But, until now, this treatment has not been studied in infants or children admitted to hospitals with cardiac arrest.

April 15, 2015

NIH launches largest clinical trial focused on HIV-related cardiovascular disease

Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID).

Subscribe to NHLBI In The News
March 25, 2015 : UPMC/University of Pittsburgh Schools of the Health Sciences

NHLBI-supported researchers from the University of Pittsburgh School of Medicine have identified a group of genes that appear to play a key role in the development of congenital heart disease, the most common type of birth defect.  The study, conducted in mice, appears in the journal Nature

March 12, 2015 : Gladstone Institutes
Gail D Pearson M.D., Sc.D., Jonathan R. Kaltman M.D.

NHLBI-supported scientists at the Gladstone Institutes have discovered why some heart tissue turns into bone, and they may have learned how to stop it.

September 29, 2015 to September 30, 2015
Natcher Conference Center (Building 45), National Institutes of Health, Bethesda, Maryland
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodelling and inflammation, vascular remodelling and inflammation, and tissue engineering/genome editing/new technologies. The emphasis will be on recent discoveries and trends. We will examine the challenges and critical questions that require answers as the field moves forward to clinical applications. The Symposium’s goals are to help the science and field move forward, to find consensus regarding the translation of stem cell biology and research into a clinical setting, and to inspire participants in their own work.